Prolactin and autoimmunity

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Shelly, Shahar ^a   Boaz, Mona ^a   Orbach, Hedi ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Autoimmune; Lupus; Multiple sclerosis; Peripartum cardiomyopathy; Prolactin; Systemic sclerosis

Indexed keywords

BROMOCRIPTINE; INTERLEUKIN 2 RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR;

AMENORRHEA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BEHCET DISEASE; CELIAC DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GALACTORRHEA; GENETIC ANALYSIS; HASHIMOTO DISEASE; HEPATITIS C; HYPERPROLACTINEMIA; IMMUNOMODULATION; MENARCHE; MENSTRUATION DISORDER; MULTIPLE SCLEROSIS; PERIPARTUM CARDIOMYOPATHY; PROLACTIN BLOOD LEVEL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE;

AMENORRHEA; AUTOIMMUNE DISEASES; AUTOIMMUNITY; ESTROGENS; FEMALE; GALACTORRHEA; HUMANS; HYPERPROLACTINEMIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROLACTIN;

EID: 84858450245     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.009     Document Type: Review

References (108)

1. Chikanza I.C. Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci 1999, 876:119-130.
2. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000, 80:1523-1631.
3. Rivero A., Garcia-Calvo A. Biochemical diagnosis of monomeric hyperprolactinemia. An Sist Sanit Navar 2011, 34:145-152.
4. Peeva E., Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005, 101:123-143.
5. Kostrzak A., Meczekalski B. Macroprolactinaemia. Pol Merkur Lekarski 2010, 29:47-49.
6. Pena K.S., Rosenfeld J.A. Evaluation and treatment of galactorrhea. Am Fam Physician 2001, 63:1763-1770.
7. Prolactin Frantz A.G. N Engl J Med 1978, 298:201-207.
8. Reuman P.D. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma. Arthritis Rheum 2004, 50:3616-3618.
9. Hietala M., Olsson H., Jernstrom H. Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk. Fam Cancer 2008, 7:221-228.
10. Berinder K., Akre O., Granath F., Hulting A.L. Cancer risk in hyperprolactinemia patients: a population-based cohort study. Eur J Endocrinol 2011, 165:209-215.
11. Reuwer A.Q., van Eijk M., Houttuijn-Bloemendaal F.M., van der Loos C.M., Claessen N., Teeling P., et al. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?. J Endocrinol 2011, 208:107-117.
12. McMurray R.W. Estrogen, prolactin, and autoimmunity: actions and interactions. Int Immunopharmacol 2001, 1:995-1008.
13. Vera-Lastra O., Jara L.J., Espinoza L.R. Prolactin and autoimmunity. Autoimmun Rev 2002, 1:360-364.
14. Bole-Feysot C., Goffin V., Edery M., Binart N., Kelly P.A. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998, 19:225-268.
15. Moreno J., Varas A., Vicente A., Zapata A.G. Role of prolactin in the recovered T-cell development of early partially decapitated chicken embryo. Dev Immunol 1998, 5:183-195.
16. Krumenacker J.S., Buckley D.J., Leff M.A., McCormack J.T., de Jong G., Gout P.W., et al. Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. Endocrine 1998, 9:163-170.
17. Buckley A.R. Prolactin, a lymphocyte growth and survival factor. Lupus 2001, 10:684-690.
18. Kochendoerfer S.K., Krishnan N., Buckley D.J., Buckley A.R. Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells. J Endocrinol 2003, 178:265-273.
19. Gado K., Pallinger E., Kovacs P., Takacs E., Szilvasi I., Toth B.E., et al. Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. Immunol Lett 2002, 82:191-196.
20. Saha S., Gonzalez J., Rosenfeld G., Keiser H., Peeva E. Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 2009, 60:1743-1752.
21. Saha S., Tieng A., Pepeljugoski K.P., Zandamn-Goddard G., Peeva E. Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models. Clin Rev Allergy Immunol 2011, 40:8-15.
22. Matera L., Mori M., Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 2001, 10:728-734.
23. Lahat N., Miller A., Shtiller R., Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 1993, 47:35-40.
24. Krause I., Blumenfeld Z., Malchinsky M., Cohen S., Blank M., Eldor A., et al. Anti-endothelial cell antibodies in the sera of hyperprolactinemic women. Lupus 1998, 7:377-382.
25. Jara L.J., Lavalle C., Fraga A., Gomez-Sanchez C., Silveira L.H., Martinez-Osuna P., et al. Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum 1991, 20:273-284.
26. Cesario T.C., Yousefi S., Carandang G., Sadati N., Le J., Vaziri N. Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells. Proc Soc Exp Biol Med 1994, 205:89-95.
27. Vidaller A., Llorente L., Larrea F., Mendez J.P., Alcocer-Varela J., Alarcon-Segovia D. T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin Immunol Immunopathol 1986, 38:337-343.
28. Jara L.J., Irigoyen L., Ortiz M.J., Zazueta B., Bravo G., Espinoza L.R. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 1998, 17:110-114.
29. Jara L.J., Benitez G., Medina G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev 2008, 7:251-255.
30. Allen S.H., Sharp G.C., Wang G., Conley C., Takeda Y., Conroy S.E., et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 1996, 5:30-37.
31. Biller B.M., Luciano A., Crosignani P.G., Molitch M., Olive D., Rebar R., et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med 1999, 44:1075-1084.
32. Miyai K., Ichihara K., Kondo K., Mori S. Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin. Clin Endocrinol (Oxf) 1986, 25:549-554.
33. Bolyakov A., Paduch D.A. Prolactin in men's health and disease. Curr Opin Urol 2011, 21:527-534.
34. Mann W.A. Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach. Eur J Clin Invest 2011, 41:334-342.
35. Colao A., Savastano S. Medical treatment of prolactinomas. Nat Rev Endocrinol 2011, 7:267-278.
36. Hoffman A.R., Melmed S., Schlechte J. Patient guide to hyperprolactinemia diagnosis and treatment. J Clin Endocrinol Metab 2011, 96:35A-36A.
37. Serri O., Chik C.L., Ur E., Ezzat S. Diagnosis and management of hyperprolactinemia. CMAJ 2003, 169:575-581.
38. Orbach H., Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007, 6:537-542.
39. Cejkova P., Fojtikova M., Cerna M. Immunomodulatory role of prolactin in diabetes development. Autoimmun Rev 2009, 9:23-27.
40. Buskila D., Lorber M., Neumann L., Flusser D., Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996, 23:629-632.
41. Szyper-Kravitz M., Zandman-Goddard G., Lahita R.G., Shoenfeld Y. The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum Dis Clin North Am 2005, 31:161-175.
42. Leanos-Miranda A., Cardenas-Mondragon G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford) 2006, 45:97-101.
43. Rezaieyazdi Z., Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol Int 2006, 26:1036-1039.
44. Orbach H., Zandman-Goddard G., Boaz M., Agmon-Levin N., Amital H., Szekanecz Z., et al. Prolactin and autoimmunity : hyperprolactinemia correlates with serositis and anemia in SLE Patients. Clin Rev Allergy Immunol 2011, Feb 3 [Electronic publication ahead of print].
45. Pacilio M., Migliaresi S., Meli R., Ambrosone L., Bigliardo B., Di Carlo R. Elevated bioactive prolactin levels in systemic lupus erythematosus-association with disease activity. J Rheumatol 2001, 28:2216-2221.
46. Jacobi A.M., Rohde W., Ventz M., Riemekasten G., Burmester G.R., Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 2001, 10:554-561.
47. Cardenas-Mondragon G., Ulloa-Aguirre A., Isordia-Salas I., Goffin V., Leanos-Miranda A. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays. J Rheumatol 2007, 34:1514-1521.
48. Jara L.J., Vera-Lastra O., Miranda J.M., Alcala M., Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus 2001, 10:748-756.
49. Leanos-Miranda A., Chavez-Rueda K.A., Blanco-Favela F. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis Rheum 2001, 44:866-875.
50. Leanos A., Pascoe D., Fraga A., Blanco-Favela F. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 1998, 7:398-403.
51. Leanos-Miranda A., Pascoe-Lira D., Chavez-Rueda K.A., Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol 2001, 28:1546-1553.
52. McMurray R., Keisler D., Kanuckel K., Izui S., Walker S.E. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991, 147:3780-3787.
53. Blank M., Krause I., Buskila D., Teitelbaum D., Kopolovic J., Afek A., et al. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol 1995, 162:114-122.
54. Walker S.E. Bromocriptine treatment of systemic lupus erythematosus. Lupus 2001, 10:762-768.
55. Jara L.J., Medina G., Saavedra M.A., Vera-Lastra O., Navarro C. Prolactin and autoimmunity. Clin Rev Allergy Immunol 2011, 40:50-59.
56. McMurray R.W., Weidensaul D., Allen S.H., Walker S.E. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 1995, 22:2084-2091.
57. Alvarez-Nemegyei J., Cobarrubias-Cobos A., Escalante-Triay F., Sosa-Munoz J., Miranda J.M., Jara L.J. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 1998, 7:414-419.
58. Jara L.J., Cruz-Cruz P., Saavedra M.A., Medina G., Garcia-Flores A., Angeles U., et al. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann N Y Acad Sci 2007, 1110:297-304.
59. Jara L.J., Pacheco-Reyes H., Medina G., Angeles U., Cruz-Cruz P., Saavedra M.A. Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci 2007, 1108:218-226.
60. Fojtikova M., Tomasova Studynkova J., Filkova M., Lacinova Z., Gatterova J., Pavelka K., et al. Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage. Clin Exp Rheumatol 2010, 28:849-854.
61. Chikanza I.C. The neuroendocrine immunology of rheumatoid arthritis. Baillieres Clin Rheumatol 1996, 10:273-293.
62. Mateo L., Nolla J.M., Bonnin M.R., Navarro M.A., Roig-Escofet D. High serum prolactin levels in men with rheumatoid arthritis. J Rheumatol 1998, 25:2077-2082.
63. Gutierrez M.A., Garcia M.E., Rodriguez J.A., Mardonez G., Jacobelli S., Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999, 26:277-281.
64. Berczi I., Cosby H., Hunter T., Baragar F., McNeilly A.S., Friesen H.G. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Br J Rheumatol 1987, 26:433-436.
65. Nagy E., Chalmers I.M., Baragar F.D., Friesen H.G., Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991, 18:1662-1668.
66. Hampl J.S., Papa D.J. Breastfeeding-related onset, flare, and relapse of rheumatoid arthritis. Nutr Rev 2001, 59:264-268.
67. McMurray R.W., Allen S.H., Pepmueller P.H., Keisler D., Cassidy J.T. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity. J Rheumatol 1995, 22:1577-1580.
68. Kucharz E.J., Jarczyk R., Jonderko G., Rubisz-Brezezinska J., Brzezinska-Wcislo L. High serum level of prolactin in patients with systemic sclerosis. Clin Rheumatol 1996, 15:314.
69. Straub R.H., Zeuner M., Lock G., Scholmerich J., Lang B. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol 1997, 36:426-432.
70. Mirone L., Barini A. Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity. Ann N Y Acad Sci 2006, 1069:257-262.
71. La Montagna G., Baruffo A., Pasquali D., Bellastella A., Tirri G., Sinisi A.A. Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis. Rheumatology (Oxford) 2001, 40:310-314.
72. Hilty C., Bruhlmann P., Sprott H., Gay R.E., Michel B.A., Gay S., et al. Altered diurnal rhythm of prolactin in systemic sclerosis. J Rheumatol 2000, 27:2160-2165.
73. Czuwara-Ladykowska J., Sicinska J., Olszewska M., Uhrynowska-Tyszkiewicz I., Rudnicka L. Prolactin synthesis by lymphocytes from patients with systemic sclerosis. Biomed Pharmacother 2006, 60:152-155.
74. Markianos M., Koutsis G., Evangelopoulos M.E., Mandellos D., Sfagos C. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis. J Neuroendocrinol 2010, 22:503-508.
75. Da Costa R., Szyper-Kravitz M., Szekanecz Z., Csepany T., Danko K., Shapira Y., et al. Ferritin and prolactin levels in multiple sclerosis. Isr Med Assoc J 2011, 13:91-95.
76. Kira J., Harada M., Yamaguchi Y., Shida N., Goto I. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991, 102:61-66.
77. Nociti V., Frisullo G., Tartaglione T., Patanella A.K., Iorio R., Tonali P.A., et al. Multiple sclerosis attacks triggered by hyperprolactinemia. J Neurooncol 2010, 98:407-409.
78. Bergh F., Kumpfel T., Schumann E., Held U., Schwan M., Blazevic M., et al. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis-reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol 2006, 6:19.
79. Orbach H., Zandman-Goddard G., Amital H., Barak V., Szekanecz Z., Szucs G., et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 2007, 1109:385-400.
80. Haga H.J., Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome. J Rheumatol 1999, 26:1291-1295.
81. Steinfeld S., Rommes S., Francois C., Decaestecker C., Maho A., Appelboom T., et al. Big prolactin 60 kDa is overexpressed in salivary glandular epithelial cells from patients with Sjogren's syndrome. Lab Invest 2000, 80:239-247.
82. El Miedany Y.M., Ahmed I., Moustafa H., El Baddini M. Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation?. Joint Bone Spine 2004, 71:203-208.
83. Taiym S., Haghighat N., Al-Hashimi I. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 97:579-583.
84. Legakis I., Petroyianni V., Saramantis A., Tolis G. Elevated prolactin to cortisol ratio and polyclonal autoimmune activation in Hashimoto's thyroiditis. Horm Metab Res 2001, 33:585-589.
85. Notsu K., Ito Y., Furuya H., Ohguni S., Kato Y. Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis. Endocr J 1997, 44:89-94.
86. Yamamoto M., Iguchi G., Takeno R., Okimura Y., Sano T., Takahashi M., et al. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest 2011, 121:113-119.
87. Kanda N., Shibata S., Tada Y., Nashiro K., Tamaki K., Watanabe S. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 2009, 39:996-1006.
88. Kanda N., Watanabe S. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 2007, 148:2317-2325.
89. Giasuddin A.S., El-Sherif A.I., El-Ojali S.I. Prolactin: does it have a role in the pathogenesis of psoriasis?. Dermatology 1998, 197:119-122.
90. Sousa G.M., Oliveira R.C., Pereira M.M., Parana R., Sousa-Atta M.L., Atta A.M. Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev 2011, 10:210-213.
91. Zennaro R., Petracca E.G., Paolini R., Ramazzina E. Normalization of the prolactin values during alfa-interferon therapy: the considerations with a female patient with anti-HCV-positive chronic hepatitis and prolactin-secreting hypophyseal microadenoma. Clin Ter 1996, 147:169-171.
92. Proenca H., Ferreira C., Miranda M., Castanheira-Dinis A., Monteiro-Grillo M. Serum prolactin levels and Behcet disease. Eur J Ophthalmol 2007, 17:404-407.
93. Atasoy M., Karatay S., Yildirim K., Kadi M., Erdem T., Senel K. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease. Cell Biochem Funct 2006, 24:353-356.
94. Houman H., Ben Ghorbel I., Lamloum M., Feki M., Khanfir M., Mebazaa A., et al. Prolactin levels in Behcet's disease: no correlation with disease manifestations and activity. Ann Med Interne (Paris) 2001, 152:209-211.
95. Keser G., Oksel F., Ozgen G., Aksu K., Doganavsargil E. Serum prolactin levels in Behcet's syndrome. Clin Rheumatol 1999, 18:351-352.
96. Yamac H., Bultmann I., Sliwa K., Hilfiker-Kleiner D. Prolactin: a new therapeutic target in peripartum cardiomyopathy. Heart 2010, 96:1352-1357.
97. Sliwa K., Fett J., Elkayam U. Peripartum cardiomyopathy. Lancet 2006, 368:687-693.
98. Cruz M.O., Briller J., Hibbard J.U. Update on peripartum cardiomyopathy. Obstet Gynecol Clin North Am 2010, 37:283-303.
99. Hilfiker-Kleiner D., Kaminski K., Podewski E., Bonda T., Schaefer A., Sliwa K., et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007, 128:589-600.
100. Hilfiker-Kleiner D., Sliwa K., Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med 2008, 18:173-179.
101. Sliwa K., Blauwet L., Tibazarwa K., Libhaber E., Smedema J.P., Becker A., et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010, 121:1465-1473.
102. Reifen R., Buskila D., Maislos M., Press J., Lerner A. Serum prolactin in coeliac disease: a marker for disease activity. Arch Dis Child 1997, 77:155-157.
103. Kapur G., Patwari A.K., Narayan S., Anand V.K. Serum prolactin in celiac disease. J Trop Pediatr 2004, 50:37-40.
104. Proenca H., Ferreira C., Miranda M., Castanheira-Dinis A., Monteiro-Grillo M. Serum prolactin levels in HLA-B27-associated uveitis. Eur J Ophthalmol 2008, 18:929-933.
105. Pleyer U., Gupta D., Weidle E.G., Lisch W., Zierhut M., Thiel H.J. Elevated prolactin levels in human aqueous humor of patients with anterior uveitis. Graefes Arch Clin Exp Ophthalmol 1991, 229:447-451.
106. Palestine A.G., Muellenberg-Coulombre C.G., Kim M.K., Gelato M.C., Nussenblatt R.B. Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat. J Clin Invest 1987, 79:1078-1081.
107. Palestine A.G., Nussenblatt R.B., Gelato M. Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine. Transplant Proc 1988, 20:131-135.
108. Zierhut M., Thiel H.J., Pleyer U., Waetjen R., Weidle E.G. Bromocriptine in therapy of chronic recurrent anterior uveitis. Fortschr Ophthalmol 1991, 88:161-164.